The common side effects reported are similar to GLP-1 agonists, and include nausea, vomiting, diarrhea, abdominal discomfort, bloating, and constipation
Beyond FSP1 there are therapeutic opportunities across the CoQ 10 oxidoreductase network While FSP1 currently has the strongest targetability signal, other CoQ 10 oxidoreductases may be therapeutically leveraged in defined genetic, metabolic or tissue contexts: (1) DHODH axis (mitochondrial defense in select contexts): DHODH connects pyrimidine synthesis to mitochondrial CoQ reduction, and in some settings, DHODH inhibition has been proposed to heighten ferroptosis sensitivity, especially in GPX4-low states
The difference here is because this is a hormone that is naturally produced in the body
Semaglutide changes the way your body uses insulin, which can also affect estrogen, cortisol, and thyroid balance
Antidiabetic drugs with limited evidence for tumor risk association -Glucosidase inhibitors As an antidiabetic drug, -glucosidase inhibitors primarily act by inhibiting the breakdown of complex carbohydrates in the gastrointestinal tract, thereby slowing their absorption and mitigating postprandial hyperglycemia
The combination does not necessarily preclude either intervention, but thyroid function should be tested before starting, at six weeks, and at three months to ensure levels remain within range